What we're reading

Before the FDA withdrew its waiver to stockpile the drugs as COVID-19 treatments, the Trump admin embarked on an effort to tens of millions of doses

U.N. agency has received no formal notice of withdrawal, raising hopes U.S. won’t follow through

Trump’s penchant for going it alone makes little sense in a world defined by global challenges that can best be met through collective action

Statistical methods were used to generate estimates of patient impact and hospital capacity measures that are representative at the state level

The nationwide lockdown has had an impact on cancer care, since Mumbai is a major destination for cancer treatment for patients from other states

China sat on releasing the genome of the virus for more than a week after three different government labs had fully decoded the information

Prevention and treatment services for noncommunicable diseases have been severely disrupted since the COVID-19 pandemic began

Near-real-time data on carbon emissions reveal the sectors, countries and events that had the most impact but it is unclear how long the dip will last

On Friday the Food and Drug Administration gave emergency authorization to Remdesivir to treat coronavirus patients

Even small differences in timing would have prevented the worst exponential growth, which by April had subsumed major U.S. cities

How to Make Sure Patents Don’t Stand in the Way of Global Health

Exploring different genomic features of RNA viruses that correlate with the incubation times and providing a predictive model